PediCAP surpasses 25% patient recruitment milestone

The PediCAP trial has successfully passed the 25% recruitment milestone with more than 400 patients successfully randomised into their arms. The PediCAP trial will determine whether children hospitalised for severe or very severe pneumonia, do better on co-amoxiclav or amoxicillin oral step-down therapy and how long these children should continue to receive antibiotic treatment.